Portal pressure reductions induced by nonselective beta‐blockers improve outcomes and decrease mortality in patients with cirrhosis with and without ascites
Laura Turco, Guadalupe García‐Tsao – 2 June 2022
Laura Turco, Guadalupe García‐Tsao – 2 June 2022
Kyle A. Soltys, George V. Mazariegos – 2 June 2022
David M. Salerno, Grace S. Lee‐Riddle, Seema Brar, Benjamin Samstein, Robert S. Brown,, Christine Lennon – 2 June 2022
Tomotake Shirono, Hideki Iwamoto, Takashi Niizeki, Shigeo Shimose, Akira Kajiwara, Hiroyuki Suzuki, Naoki Kamachi, Yu Noda, Shusuke Okamura, Masahito Nakano, Ryoko Kuromatsu, Kenta Murotani, Hironori Koga, Takuji Torimura – 2 June 2022 – In 2013 and 2014, the development of microcatheters with balloons for the 4‐Fr system and new embolization materials provided various options for transarterial chemoembolization (TACE), expanding the range of treatment strategies.
Kayvan Mohkam, David Nasralla, Hynek Mergental, Xavier Muller, Andrew Butler, Wayel Jassem, Charles Imber, Diethard Monbaliu, M. Thamara P. R. Perera, Richard W. Laing, Juan Carlos García‐Valdecasas, Andreas Paul, Federica Dondero, François Cauchy, Eric Savier, Olivier Scatton, Fabien Robin, Laurent Sulpice, Petru Bucur, Ephrem Salamé, Gabriella Pittau, Marc‐Antoine Allard, Pierre Pradat, Guillaume Rossignol, Jean‐Yves Mabrut, Rutger J. Ploeg, Peter J. Friend, Darius F.
Laura Turco, Guadalupe García‐Tsao – 2 June 2022
Jody C. Olson, Richard K. Gilroy – 2 June 2022
AASLD is pleased to announce the election of new Governing Board and Foundation Board members who will begin their terms in...
The American Association for the Study of Liver Diseases (AASLD) has appointed Matthew R. D’Uva, FASAE, CAE, as its new chief...
Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the...